Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines
- PMID: 39349521
- PMCID: PMC11443006
- DOI: 10.1038/s41598-024-72418-8
Impact of essential genes on the success of genome editing experiments generating 3313 new genetically engineered mouse lines
Abstract
The International Mouse Phenotyping Consortium (IMPC) systematically produces and phenotypes mouse lines with presumptive null mutations to provide insight into gene function. The IMPC now uses the programmable RNA-guided nuclease Cas9 for its increased capacity and flexibility to efficiently generate null alleles in the C57BL/6N strain. In addition to being a valuable novel and accessible research resource, the production of 3313 knockout mouse lines using comparable protocols provides a rich dataset to analyze experimental and biological variables affecting in vivo gene engineering with Cas9. Mouse line production has two critical steps - generation of founders with the desired allele and germline transmission (GLT) of that allele from founders to offspring. A systematic evaluation of the variables impacting success rates identified gene essentiality as the primary factor influencing successful production of null alleles. Collectively, our findings provide best practice recommendations for using Cas9 to generate alleles in mouse essential genes, many of which are orthologs of genes linked to human disease.
Keywords: Cas9; Genome editing; Knockout; Mouse.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
MeSH terms
Grants and funding
- UM1OD023221/NH/NIH HHS/United States
- U42OD011185/NH/NIH HHS/United States
- OGI-051/Genome Canada
- UM1 OD023221/OD/NIH HHS/United States
- U42OD011175/NH/NIH HHS/United States
- LM2018126/Ministry of Education, Youth and Sports of the Czech Republic
- OGI-137/Genome Canada
- OGI-090/Ontario Genomics
- ANR-10-IDEX-0002-02/Institut National de la Santé et de la Recherche Médicale
- MC_UP_1502/3/MRC_/Medical Research Council/United Kingdom
- OGI-090/Genome Canada
- OGI-137/Ontario Genomics
- UM1 OD023222/OD/NIH HHS/United States
- ANR-10-INBS-07/Institut National de la Santé et de la Recherche Médicale
- UM1HG006370/NH/NIH HHS/United States
- U42OD011174/NH/NIH HHS/United States
- UM1 HG006348/HG/NHGRI NIH HHS/United States
- U42 OD011174/OD/NIH HHS/United States
- OGI-051/Ontario Genomics
- UM1 HG006370/HG/NHGRI NIH HHS/United States
- UMIHG006348/NH/NIH HHS/United States
- ANR-10-LABX-0030-INRT/Institut National de la Santé et de la Recherche Médicale
- U42 OD011175/OD/NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- U42 OD011185/OD/NIH HHS/United States
- RVO 68378050/Czech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences
- UM1OD023222/NH/NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
